Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,925
Closed -$204K 2174
2025
Q4
$204K Buy
59,925
+12,525
+26% +$60.8K ﹤0.01% 1740
2025
Q3
$322K Sell
47,400
-467,652
-91% -$3.86M ﹤0.01% 1445
2025
Q2
$7.02M Buy
515,052
+346,171
+205% +$3.27M 0.08% 321
2025
Q1
$919K Buy
168,881
+69,502
+70% +$394K 0.01% 858
2024
Q4
$492K Buy
99,379
+38,722
+64% +$203K 0.01% 1085
2024
Q3
$318K Sell
60,657
-62,637
-51% -$361K 0.01% 1278
2024
Q2
$846K Buy
123,294
+14,785
+14% +$135K 0.02% 896
2024
Q1
$1.12M Sell
108,509
-3,229
-3% -$23.9K 0.03% 745
2023
Q4
$926K Buy
111,738
+37,339
+50% +$268K 0.03% 759
2023
Q3
$465K Buy
+74,399
New +$322K 0.02% 1061

Other funds holding LFMD

Jump Financial's LFMD Position: Q1 2026 in Review

Jump Financial sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 59,925 shares — an estimated $204K sold.

Jump Financial first reported a position in LFMD in Q3 2023 and held it in 10 quarters. The position peaked at $7.02M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Jump Financial reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 59,925 LifeMD shares in Q1 2026, an estimated $204K.
  • Jump Financial first reported a position in LifeMD in Q3 2023 and held it in 10 quarters.
  • Jump Financial's LifeMD position peaked at $7.02M in Q2 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.